Answers are grounded in this paper and cite their sources.
Topical INFa-2b may be an effective treatment for primary conjunctival intraepithelial neoplasia.
Conjunctival intraepithelial neoplasia (CIN) is the most common conjunctival malignancy in the United States. It occurs in exposed areas of the bulbar conjunctiva with frequent involvement of the adjacent corneal epithelium. Recent studies 1 have noted a recurrence rate of about 50% when there is pathological evidence of residual tumour in the surgical margin and a 5-33% recurrence rate with clear margins. 2 We describe two cases of primary CIN successfully treated with topical INFa-2b.
No takes yet. Share an insight, caveat, or question.
William E. Adams (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: